Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 191

1.

Anticoagulation therapy for atrial fibrillation.

Hylek EM.

Semin Thromb Hemost. 2013 Mar;39(2):147-52. doi: 10.1055/s-0033-1334812. Epub 2013 Feb 8. Review.

PMID:
23397554
[PubMed - indexed for MEDLINE]
2.

Novel oral anticoagulants for stroke prevention in atrial fibrillation: focus on apixaban.

Potpara TS, Polovina MM, Licina MM, Stojanovic RM, Prostran MS, Lip GY.

Adv Ther. 2012 Jun;29(6):491-507. doi: 10.1007/s12325-012-0026-8. Epub 2012 Jun 7. Review.

PMID:
22684583
[PubMed - indexed for MEDLINE]
3.

Comparative efficacy and safety of new oral anticoagulants in patients with atrial fibrillation.

Schneeweiss S, Gagne JJ, Patrick AR, Choudhry NK, Avorn J.

Circ Cardiovasc Qual Outcomes. 2012 Jul 1;5(4):480-6. doi: 10.1161/CIRCOUTCOMES.112.965988. Epub 2012 Jul 10.

PMID:
22787066
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

New oral anticoagulants for atrial fibrillation: a review of clinical trials.

O'Dell KM, Igawa D, Hsin J.

Clin Ther. 2012 Apr;34(4):894-901. doi: 10.1016/j.clinthera.2012.01.019. Epub 2012 Mar 13. Review.

PMID:
22417716
[PubMed - indexed for MEDLINE]
5.

Prevention of stroke in patients with atrial fibrillation.

Olsson SB, Halperin JL.

Semin Vasc Med. 2005 Aug;5(3):285-92. Review.

PMID:
16123916
[PubMed - indexed for MEDLINE]
6.

A review of oral anticoagulants in patients with atrial fibrillation.

Greenspon AJ.

Postgrad Med. 2012 Nov;124(6):7-16. doi: 10.3810/pgm.2012.11.2608. Review.

PMID:
23322134
[PubMed - indexed for MEDLINE]
7.

Recent advances in antithrombotic therapy for stroke prevention in patients with atrial fibrillation.

Lenchus JD.

Hosp Pract (1995). 2013 Feb;41(1):49-60. doi: 10.3810/hp.2013.02.1007.

PMID:
23466967
[PubMed - indexed for MEDLINE]
8.

An indirect comparison of dabigatran, rivaroxaban and apixaban for atrial fibrillation.

Mantha S, Ansell J.

Thromb Haemost. 2012 Sep;108(3):476-84. doi: 10.1160/TH12-02-0093. Epub 2012 Jun 28. Review.

PMID:
22740145
[PubMed - indexed for MEDLINE]
9.

Novel oral anticoagulants for stroke prevention in patients with atrial fibrillation.

Berman JP, Halperin JL.

Hosp Pract (1995). 2013 Feb;41(1):37-48. doi: 10.3810/hp.2013.02.1006. Review.

PMID:
23466966
[PubMed - indexed for MEDLINE]
10.

Emerging anticoagulant therapies for atrial fibrillation: new options, new challenges.

Mangiafico RA, Mangiafico M.

Curr Med Chem. 2012;19(27):4688-98. Review.

PMID:
22830344
[PubMed - indexed for MEDLINE]
11.

Oral IIa and Xa inhibitors for prevention of stroke in atrial fibrillation: clinical studies and regulatory considerations.

Deftereos S, Tsounis D, Giannopoulos G, Kossyvakis C, Panagopoulou V, Raisakis K, Stefanadis C.

Curr Clin Pharmacol. 2012 Aug;7(3):166-74. Review.

PMID:
22564122
[PubMed - indexed for MEDLINE]
12.

Direct thrombin and factor Xa inhibition for stroke prevention in patients with atrial fibrillation.

Galanis T, Merli GJ.

Hosp Pract (1995). 2013 Feb;41(1):26-36. doi: 10.3810/hp.2013.02.1010. Review.

PMID:
23466965
[PubMed - indexed for MEDLINE]
13.

Anticoagulant prevention in patients with atrial fibrillation: alternatives to vitamin K antagonists.

Kozlowski D, Budrejko S, Raczak G, Rysz J, Banach M.

Curr Pharm Des. 2013;19(21):3816-26. Review.

PMID:
23286429
[PubMed - indexed for MEDLINE]
14.

Antithrombotic therapies for stroke prevention in atrial fibrillation.

Economides Muñoz C, Singh BN.

Minerva Cardioangiol. 2004 Apr;52(2):125-39. Review.

PMID:
15194994
[PubMed - indexed for MEDLINE]
Free Article
15.

Meta-analysis of efficacy and safety of new oral anticoagulants (dabigatran, rivaroxaban, apixaban) versus warfarin in patients with atrial fibrillation.

Miller CS, Grandi SM, Shimony A, Filion KB, Eisenberg MJ.

Am J Cardiol. 2012 Aug 1;110(3):453-60. doi: 10.1016/j.amjcard.2012.03.049. Epub 2012 Apr 24. Review.

PMID:
22537354
[PubMed - indexed for MEDLINE]
16.

Stroke prevention in atrial fibrillation: impact of novel oral anticoagulants.

Haft JI.

Clin Appl Thromb Hemost. 2013 Jun;19(3):241-8. doi: 10.1177/1076029612458148. Epub 2012 Sep 4. Review.

PMID:
22952215
[PubMed - indexed for MEDLINE]
17.

Stroke in atrial fibrillation: update on pathophysiology, new antithrombotic therapies, and evolution of procedures and devices.

Savelieva I, Bajpai A, Camm AJ.

Ann Med. 2007;39(5):371-91.

PMID:
17701479
[PubMed - indexed for MEDLINE]
18.

[New treatments for stroke and thromboembolism prevention in atrial fibrillation].

Shiyovich A, Khalameizer V, Katz A.

Harefuah. 2014 Jan;153(1):32-8, 64. Review. Hebrew.

PMID:
24605405
[PubMed - indexed for MEDLINE]
19.

Dabigatran and factor Xa inhibitors for stroke prevention in patients with nonvalvular atrial fibrillation.

Uchiyama S, Ibayashi S, Matsumoto M, Nagao T, Nagata K, Nakagawara J, Tanahashi N, Tanaka K, Toyoda K, Yasaka M.

J Stroke Cerebrovasc Dis. 2012 Apr;21(3):165-73. doi: 10.1016/j.jstrokecerebrovasdis.2012.01.011. Review.

PMID:
22440950
[PubMed - indexed for MEDLINE]
20.

Randomized controlled trials of new oral anticoagulants for stroke prevention in atrial fibrillation.

Liew A, Eikelboom JW, O'Donnell M.

Curr Opin Cardiol. 2012 Jul;27(4):331-9. doi: 10.1097/HCO.0b013e3283540857. Review.

PMID:
22573171
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk